Dr. rer. nat. Stephanie Stölting
- Functional relevance of nexilin in dilated cardiomyopathy and systolic dysfunction
- Protein-protein interactions in disease
2013 – ongoing
Post doc (part time) Institute for Integrative and Experimental Genomics at the r University of Lübeck
2012 – 2012
Post doc (part time) Medizinische Klinik II, UKSH Lübeck
2009 – 2011
Freelance consultant for tissue removal authorization
2006 – 2008
Quality management representative HÄLSA Pharma (DiapharmGruppe) a representative for medical devices (part time)
2005 – 2008
Projectmanagement DiapharmGruppe with the main focus certification of biotechnolgical products, in- vitro diagnostica and pharmaceutical medical devices (part time)
2003 – 2005
Consultant DiapharmGruppe with the main focus certification of biotechnological products and in- vitro diagnostic (part time)
2002 – ongoing
Postdoc (part time) Department of hematology and oncology, Medizinische Klinik I, UKSH Lübeck
1998 – 2002
Phd thesis Medizinische Klinik II, Universitätsklinikum Lübeck
Titel: Charakterisierung des Myosinbindeproteins-C in Embryoid Bodies anhand von „Knock-in“- und „Knock-out“-Mutationen
1998 – 1998
Scientific participation at the lab for transport protein research of Dr. H. Jung, University of Osnabrück
1997 – 1998
Diploma thesis at the lab for transport protein research of Dr. H. Jung, University of Osnabrück
- Deutsches Zentrum für Herz-Kreislauf Forschung e.V. (DZHK)
Pharmaceutical industry
Funding Period: 2007-2013Amount: 90.000,–€
Foundations
Funding Period: 2012-2014Amount: 10.000,–€